Lv1
80 积分 2025-05-06 加入
Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano–bio interactions
2小时前
已完结
Lipid nanoparticles for siRNA delivery in cancer treatment
2小时前
已完结
Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy
5小时前
已完结
Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy
5小时前
已完结
Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy
5小时前
已完结
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers
15小时前
已完结
Nanotechnology approaches for inhalation treatment of lung diseases
8天前
已完结
Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol
8天前
已完结
Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?
8天前
已完结
Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory
9天前
已完结
皖公网安备34019202002308
